SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

Apple, Gilead, and Micron drive S&P500 and Nasdaq higher; US indices hold floors as traders weigh earnings momentum against ...

On August 7, 2025, EIA released its Weekly Natural Gas Storage Report. The report indicated that working gas in storage ...

About Vepdegestrant Vepdegestrant is an investigational, orally bioavailable PROteolysis TArgeting Chimera (PROTAC) estrogen receptor degrader. Vepdegestrant is being developed as a potential ...

Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...

Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today reported financial results for the second ...

US Health Secretary Robert F. Kennedy Jr. has slashed government spending on mRNA vaccine research. Experts warn it will boost global vulnerability to future pandemics.

The FTSE 100 edged down on Friday on a mixed day for European equities despite new optimism about an end to the war between ...

The pound rose to USD1.3450 late on Friday afternoon in London, compared to USD1.3412 at the equities close on Thursday. The euro traded at USD1.1666, higher against USD1.1631. Against the yen, the ...

Federal regulators are caught between old-guard conservatives who demand continued mRNA funding, Rep. Massie's demand to ...